Skip to main content

NGM Biopharmaceuticals Inc

NGMDelisted Apr 5, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0001426332

NGM Biopharmaceuticals Inc was delisted on Apr 5, 2024; its insiders filed their last Form 4 on Apr 8, 2024; 75 institutions reported holding it in 13F filings for Q1 2024, worth $55.1M in total; no superinvestor held it.

Q4 2023 vs. Q3 2023

How the institutions holding NGM Biopharmaceuticals Inc changed between Q3 2023 and Q4 2023.

All holders in Q4 2023All holders in Q3 2023

13F holders of NGM: Q3 2023 compared with Q4 2023
MeasureQ3 2023Q4 2023Change
Holders9583−12
Shares47.1M41.1M−6.00M (−12.7%)
Value$50.6M$35.3M−$15.3M (−30.2%)

New holders (7)

Institutions that held NGM Biopharmaceuticals Inc at the end of Q4 2023 but not at the end of Q3 2023.

Institutions new to NGM in Q4 2023
InstitutionSharesValue% of portfolio
Deutsche Bank AG212,944$183.1K0.00%
Prudential Financial Inc29,785$25.6K0.00%
Clarius Group, LLC26,606$22.9K0.00%
HRT Financial LP12,821$11.0K0.00%
US Bancorp12,751$11.0K0.00%
State Board of Administration of Florida Retirement System11,324$9.73K0.00%
GAMMA Investing LLC346$5290.00%

Sold out (19)

Institutions that held NGM Biopharmaceuticals Inc at the end of Q3 2023 and filed for Q4 2023 without it.